Board Member
Halozyme Therapeutics, Inc. (HALO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2014-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2014-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Halozyme Therapeutics, Inc. (HALO) | President and Chief Executive Officer | $1,000,000 | $23,166,223 |
| 2024 | Halozyme Therapeutics, Inc. (HALO) | President and Chief Executive Officer | $960,000 | $12,741,421 |
| 2023 | Halozyme Therapeutics, Inc. (HALO) | President and Chief Executive Officer | $920,000 | $11,820,858 |
| 2022 | Halozyme Therapeutics, Inc. (HALO) | President and Chief Executive Officer | $871,732 | $9,696,978 |
Earnings-call appearances and filed executive appointments or departures, newest first.
